Latest news
BeOne Medicines and Revolution Medicines Announce Clinical Development and Regional Commercialization Collaboration - BioSpaceBioSpace · Mon, 10 Aug 2026 12:40:13 GMTRevolution Medicines (NASDAQ:RVMD) Announces Earnings Results - MarketBeatMarketBeat · Thu, 06 Aug 2026 04:00:22 GMTRevolution Medicines reports Q2 net loss $644.4M; cash and marketable securities $3.94B - TradingViewTradingView · Wed, 05 Aug 2026 20:13:03 GMTRevolution Medicines to webcast Q2 update Aug. 5 at 4:30 p.m. - Stock TitanStock Titan · Wed, 29 Jul 2026 07:00:00 GMTRevolution Medicines (RVMD) Expected to Announce Earnings on Wednesday - MarketBeatMarketBeat · Wed, 29 Jul 2026 07:00:00 GMT